AAAAAA
Results: 26-50/194
Authors:
ESTACIO RO
JEFFERS BW
HIATT WR
BIGGERSTAFF SL
GIFFORD N
SCHRIER RW
Citation: Ro. Estacio et al., THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION, The New England journal of medicine, 338(10), 1998, pp. 645-652
Authors:
COHEN JA
JEFFERS BW
STABLER SP
BIGGERSTAFF SLB
SCHRIER RW
Citation: Ja. Cohen et al., HYPERHOMOCYSTEINEMIA IS A RISK FACTOR FOR DIABETIC AUTONOMIC NEUROPATHY, Neurology, 50(4), 1998, pp. 2056-2056
Authors:
MARTIN PY
OHARA M
GINES P
XU DL
STJOHN J
NIEDERBERGER M
SCHRIER RW
Citation: Py. Martin et al., NITRIC-OXIDE SYNTHASE (NOS) INHIBITION FOR ONE WEEK IMPROVES RENAL SODIUM AND WATER-EXCRETION IN CIRRHOTIC RATS WITH ASCITES (VOL 101, PG 235, 1998), The Journal of clinical investigation, 102(3), 1998, pp. 641-641
Authors:
OHARA M
MARTIN PY
XU DL
STJOHN J
PATTISON TA
KIM JK
SCHRIER RW
Citation: M. Ohara et al., UP-REGULATION OF AQUAPORIN-2 WATER CHANNEL EXPRESSION IN PREGNANT RATS, The Journal of clinical investigation, 101(5), 1998, pp. 1076-1083
Authors:
MARTIN PY
OHARA M
GINES P
XU DL
STJOHN J
NIEDERBERGER M
SCHRIER RW
Citation: Py. Martin et al., NITRIC-OXIDE SYNTHASE (NOS) INHIBITION FOR ONE WEEK IMPROVES RENAL SODIUM AND WATER-EXCRETION IN CIRRHOTIC RATS WITH ASCITES, The Journal of clinical investigation, 101(1), 1998, pp. 235-242
Authors:
SCHRIER RW
Citation: Rw. Schrier, RENIN-ANGIOTENSIN IN PREASCITIC CIRRHOSIS - EVIDENCE FOR PRIMARY PERIPHERAL ARTERIAL VASODILATATION, Gastroenterology, 115(2), 1998, pp. 489-491
Authors:
ESTACIO RO
SCHRIER RW
Citation: Ro. Estacio et Rw. Schrier, ANTIHYPERTENSIVE THERAPY IN TYPE-2 DIABETES - IMPLICATIONS OF THE APPROPRIATE BLOOD-PRESSURE CONTROL IN DIABETES (ABCD) TRIAL, The American journal of cardiology, 82(9B), 1998, pp. 9-14
Authors:
BARTECCHI CE
SCHRIER RW
Citation: Ce. Bartecchi et Rw. Schrier, THE PROPOSED TOBACCO DEAL - NOT SO FAST, Hospital practice, 32(8), 1997, pp. 17
Authors:
MEHLER PS
SCHRIER RW
Citation: Ps. Mehler et Rw. Schrier, ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH DIABETIC NEPHROPATHY, Kidney & blood pressure research, 20(2), 1997, pp. 74-81
Authors:
SAVAGE S
ESTACIO RO
JEFFERS B
SCHRIER RW
Citation: S. Savage et al., INCREASED COMPLICATIONS IN NONINSULIN-DEPENDENT DIABETIC-PATIENTS TREATED WITH INSULIN VERSUS ORAL HYPOGLYCEMIC AGENTS - A POPULATION STUDY, Proceedings of the Association of American Physicians, 109(2), 1997, pp. 181-189
Authors:
MARTIN PY
ABRAHAM WT
XU L
OREN RM
OLSON BR
OHARA M
SCHRIER RW
Citation: Py. Martin et al., SELECTIVE V2-RECEPTOR AVP ANTAGONISM DECREASES URINARY AQUAPORIN-2 EXCRETION IN PATIENTS WITH CHRONIC HEART-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 103-103
Authors:
OHARA M
XU LM
MARTIN PY
STJOHN J
SCHRIER RW
Citation: M. Ohara et al., EXPRESSION OF AQUAPORIN-2 IN DRUG-INDUCED ARTERIAL VASODILATION, Journal of the American Society of Nephrology, 8, 1997, pp. 110-110
Authors:
CHAPMAN A
RAYNOLDS M
JOHNSON K
YOUNG D
PERRYMAN B
SCHRIER RW
Citation: A. Chapman et al., ANGIOTENSIN-CONVERTING ENZYME (ACE) DELETION (DD) POLYMORPHISM IN HYPERTENSIVE (HBP) AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1713-1713
Authors:
CHAPMAN A
JOHNSON A
SCHRIER RW
Citation: A. Chapman et al., CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION (ACEI) THERAPY DOES NOT INHIBIT SYSTEMIC ANGIOTENSIN-II (AII) LEVELS IN HYPERTENSIVE (HBP)AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1714-1714
Authors:
SAHAI A
GRAF K
GENGARO PE
SCHRIER RW
HSUEH WA
Citation: A. Sahai et al., CHRONIC HYPOXIA INDUCES PROLIFERATION OF CULTURED VASCULAR SMOOTH-MUSCLE (VSM) CELLS - ROLE OF OSTEOPONTIN (OPN) AND NITRIC-OXIDE (NO), Journal of the American Society of Nephrology, 8, 1997, pp. 1982-1982
Authors:
SAHAI A
GENGARO PE
SCHRIER RW
Citation: A. Sahai et al., CHRONIC HYPOXIA-INDUCED PROLIFERATION OF CULTURED MESANGIAL CELLS IS ASSOCIATED WITH INCREASED OSTEOPONTIN (OPN) AND DECREASED NITRIC-OXIDE(NO) SYNTHESIS, Journal of the American Society of Nephrology, 8, 1997, pp. 1983-1983
Authors:
SAHAI A
PATTISON TA
SCHRIER RW
Citation: A. Sahai et al., ROLE OF CALCIUM-INFLUX IN HYPOXIA-INDUCED STIMULATION OF PROTEIN-KINASE-C (PKC) AND PROLIFERATION BY CULTURED RAT MESANGIAL CELLS, Journal of the American Society of Nephrology, 8, 1997, pp. 2067-2067
Authors:
EDELSTEIN CL
LING H
GENGARO PE
WANGSIRIPAISAN A
BAHR BA
NEMENOFF RA
SCHRIER RW
Citation: Cl. Edelstein et al., CALPAIN MEDIATED CHANGES IN SPECTRIN AND NAK-ATPASE IN RAT RENAL PROXIMAL TUBULES (PT), Journal of the American Society of Nephrology, 8, 1997, pp. 2729-2729
Authors:
CHAPMAN AB
JOHNSON AM
RAINGUET S
HOSSACK K
GABOW P
SCHRIER RW
Citation: Ab. Chapman et al., LEFT-VENTRICULAR HYPERTROPHY IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE, Journal of the American Society of Nephrology, 8(8), 1997, pp. 1292-1297
Authors:
SCHRIER RW
Citation: Rw. Schrier, FAMILIAL HYPOTHALAMIC DIABETES-INSIPIDUS IN RATS (BRATTLEBORO STRAIN)- COMMENTARY, Journal of the American Society of Nephrology, 8(8), 1997, pp. 1336-1341
Authors:
KIM JK
SUMMER SN
WOOD WM
BROWN JL
SCHRIER RW
Citation: Jk. Kim et al., ARGININE-VASOPRESSIN SECRETION WITH MUTANTS OF WILD-TYPE AND BRATTLEBORO RATS AVP GENE, Journal of the American Society of Nephrology, 8(12), 1997, pp. 1863-1869
Authors:
SCHRIER RW
Citation: Rw. Schrier, ENSURING THE SURVIVAL OF THE CLINICIAN-SCIENTIST, Academic medicine, 72(7), 1997, pp. 589-594
Authors:
MEHLER PS
JEFFERS BW
ESTACIO R
SCHRIER RW
Citation: Ps. Mehler et al., ASSOCIATIONS OF HYPERTENSION AND COMPLICATIONS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, American journal of hypertension, 10(2), 1997, pp. 152-161
Authors:
EDELSTEIN CL
ALKHUNAIZI AA
SCHRIER RW
Citation: Cl. Edelstein et al., THE ROLE OF CALCIUM IN THE PATHOGENESIS OF ACUTE-RENAL-FAILURE, Renal failure, 19(2), 1997, pp. 199-207
Authors:
ABRAHAM WT
OREN RM
CRISMAN TS
ROBERTSON AD
SHAKAR S
LOWES BD
PANTHER L
KELLEY P
PIES CJ
BRISTOW MR
SCHRIER RW
Citation: Wt. Abraham et al., EFFECTS OF AN ORAL, NONPEPTIDE, SELECTIVE V-2 RECEPTOR VASOPRESSIN ANTAGONIST IN PATIENTS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7271-7271